RxDoctor Payments Data

Frank Santos, MD

Psychiatry · West New York, NJNPI 1811941651

Payments from drug & device makers

$2,018in general payments, 2019–2025

Across 131 payments — averaging $15.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$384
  • Otsuka America Pharmaceutical, Inc.$255
  • Teva Pharmaceuticals USA, Inc.$239
  • AbbVie$208
  • Neurocrine Biosciences, Inc.$205
  • Sunovion Pharmaceuticals Inc.$193
  • plus $533 from 7 others

What the payments were for

  • Food & beverage$2,018100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,018 in reported general payments places this provider in the 80th percentile of 1,119 psychiatry providers in New Jersey.

See all psychiatry providers in New Jersey

Medicare billing

Part B allowed, 2024
$17,154
Medicare patients
42
Services billed
212

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate121$275,425
Lurasidone Hcl186$43,941
Abilify MaintenaAripiprazole16$38,464
Aripiprazole571$22,052
Divalproex Sodium759$11,541
Olanzapine655$9,493
Mirtazapine1,011$9,111
Memantine Hcl455$7,679
Clonazepam967$7,024
Escitalopram Oxalate1,672$6,917
Doxepin Hcl550$6,774
Memantine Hcl ErMemantine Hcl87$6,685
Bupropion XlBupropion Hcl423$6,486
Quetiapine Fumarate575$6,239
Ziprasidone Hcl120$4,735

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Invega$384$279,500132 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$255$38,46416 claims
Almatica Pharma LLCSertraline Hcl$183$2,015632 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,119 psychiatry providers in New Jersey.

Other psychiatry in West New York

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →